Hanna Janiszewska

Torun, KP, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Constitutional mutations of the CHEK2 gene are a risk factor for MDS, but not for de novo AML.

Constitutional mutations of the CHEK2 gene are a risk factor for MDS, but not for de novo AML.

Journal: Leukemia research

Published: November 16, 2017

Screening with magnetic resonance imaging, mammography and ultrasound in women at average and intermediate risk of breast cancer.

Screening with magnetic resonance imaging, mammography and ultrasound in women at average and intermediate risk of breast cancer.

Journal: Hereditary cancer in clinical practice

Published: November 11, 2016

The impact of oophorectomy on survival after breast cancer in BRCA1-positive breast cancer patients.

The impact of oophorectomy on survival after breast cancer in BRCA1-positive breast cancer patients.

Journal: Breast cancer research and treatment

Published: March 04, 2016

The germline mutations of the CHEK2 gene are associated with an increased risk of polycythaemia vera.

The germline mutations of the CHEK2 gene are associated with an increased risk of polycythaemia vera.

Journal: British journal of haematology

Published: June 19, 2015

The variant allele of the rs188140481 polymorphism confers a moderate increase in the risk of prostate cancer in Polish men.

The variant allele of the rs188140481 polymorphism confers a moderate increase in the risk of prostate cancer in Polish men.

Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)

Published: September 05, 2014

Survival from breast cancer in patients with CHEK2 mutations.

Survival from breast cancer in patients with CHEK2 mutations.

Journal: Breast cancer research and treatment

Published: October 30, 2013

A risk of breast cancer in women - carriers of constitutional CHEK2 gene mutations, originating from the North - Central Poland.

A risk of breast cancer in women - carriers of constitutional CHEK2 gene mutations, originating from the North - Central Poland.

Journal: Hereditary cancer in clinical practice

Published: October 14, 2013

Clinical characteristics of breast cancer in patients with an NBS1 mutation.

Clinical characteristics of breast cancer in patients with an NBS1 mutation.

Journal: Breast cancer research and treatment

Published: August 28, 2013

Ten-year survival in patients with BRCA1-negative and BRCA1-positive breast cancer.

Ten-year survival in patients with BRCA1-negative and BRCA1-positive breast cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 14, 2013

A common nonsense mutation of the BLM gene and prostate cancer risk and survival.

A common nonsense mutation of the BLM gene and prostate cancer risk and survival.

Journal: Gene

Published: August 13, 2013

Prevalence of the BRCA1 c.68_69delAG (BIC: 185delAG) mutation in women with breast cancer from north-central Poland and a review of the literature on other regions of the country.

Prevalence of the BRCA1 c.68_69delAG (BIC: 185delAG) mutation in women with breast cancer from north-central Poland and a review of the literature on other regions of the country.

Journal: Contemporary oncology (Poznan, Poland)

Published: June 20, 2012

A risk of essential thrombocythemia in carriers of constitutional CHEK2 gene mutations.

A risk of essential thrombocythemia in carriers of constitutional CHEK2 gene mutations.

Journal: Haematologica

Published: November 08, 2011

Showing 1-12 of 14

Last Updated: 09/26/2026